Russell Investments Group, Ltd. Satsuma Pharmaceuticals, Inc. Transaction History

Russell Investments Group, Ltd.

  • $60.3 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 29, 2022
SELL
$2.59 - $4.3 $179,619 - $298,209
-69,351 Closed
0 $0
Q1 2021

May 10, 2021
SELL
$4.57 - $7.18 $39,932 - $62,738
-8,738 Reduced 11.19%
69,351 $409,000
Q4 2020

Feb 08, 2021
BUY
$3.56 - $5.09 $277,996 - $397,473
78,089 New
78,089 $359,000

About Satsuma Pharmaceuticals, Inc.

STSA Quotes by TradingView
  • Ticker STSA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,587,500
  • Description
  • Satsuma Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, developing novel therapeutic products for the acute treatment of migraines. The company's lead product candidate is STS101, a drug-device combination of a proprietary dry-powder formulation of dihydroergotamine mesylate, which is in SUMMIT Phase 3 efficacy trials and can ...
More about STSA
Track This Portfolio

Track Russell Investments Group, Ltd. Portfolio

Follow Russell Investments Group, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email